--- title: "VISEN Pharmaceuticals (2561) stock and investor profile" url: "https://aibio.space/companies/visen-pharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "VISEN Pharmaceuticals (HKEX: 2561), China. The directory classifies it as Pharmaceuticals: Major." --- 2561 VISEN Pharmaceuticals HKEX · China # VISEN Pharmaceuticals (2561) news VISEN Pharmaceuticals is a public biotech or pharmaceutical company listed on HKEX under the ticker 2561, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest VISEN Pharmaceuticals news We have not published a story on VISEN Pharmaceuticals yet. When there is news, it will appear here. ## VISEN Pharmaceuticals at a glance - **Ticker**: 2561 - **Listing**: HKEX - **Country**: China ### Related companies - [Beijing Foyou Pharma Co.](https://aibio.space/companies/beijing-foyou-pharma/) SSE: 601089 - [Shandong Wohua Pharmaceutical Co.](https://aibio.space/companies/shandong-wohua-pharmaceutical/) SZSE: 002107 - [Harbin Gloria Pharmaceuticals Co.](https://aibio.space/companies/harbin-gloria-pharmaceuticals/) SZSE: 002437 - [Jiangsu Nhwa Pharmaceutical Co.](https://aibio.space/companies/jiangsu-nhwa-pharmaceutical/) SZSE: 002262 - [Transcenta Holding](https://aibio.space/companies/transcenta/) HKEX: 6628 - [Mabwell (Shanghai) Bioscience Co.](https://aibio.space/companies/mabwell-shanghai-bioscience/) SSE: 688062 - [Pulike Biological Engineering](https://aibio.space/companies/pulike-biological-engineering/) SSE: 603566 - [China National Medicines Corporation](https://aibio.space/companies/china-national-medicines/) SSE: 600511 ### Also on HKEX - [CARsgen Therapeutics Holdings](https://aibio.space/companies/carsgen-therapeutics/) 2171 - [CK Life Sciences International (Holdings)](https://aibio.space/companies/ck-life-sciences-international/) 775 - [TenNor Therapeutics Suzhou](https://aibio.space/companies/tennor-therapeutics-suzhou/) 6872 - [Hansoh Pharmaceutical Group Company](https://aibio.space/companies/hansoh-pharmaceutical/) 3692 - [Simcere Pharmaceutical Group](https://aibio.space/companies/simcere-pharmaceutical/) 2096 - [Ascentage Pharma Group International](https://aibio.space/companies/ascentage-pharma-international/) 6855 ## Questions about VISEN Pharmaceuticals What is the ticker symbol of VISEN Pharmaceuticals? VISEN Pharmaceuticals trades under the ticker 2561 on HKEX. Where is VISEN Pharmaceuticals listed? VISEN Pharmaceuticals is listed on HKEX. Which country or territory is VISEN Pharmaceuticals listed under? Our directory records VISEN Pharmaceuticals under China. What does VISEN Pharmaceuticals do? Our directory classifies VISEN Pharmaceuticals as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of VISEN Pharmaceuticals? The ISIN recorded for VISEN Pharmaceuticals is KYG93Y5D1039. Does aibio.space cover VISEN Pharmaceuticals? aibio.space lists VISEN Pharmaceuticals among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to VISEN Pharmaceuticals? Companies in our directory listed in the same country and business area as VISEN Pharmaceuticals: Beijing Foyou Pharma Co., Shandong Wohua Pharmaceutical Co., Harbin Gloria Pharmaceuticals Co., Jiangsu Nhwa Pharmaceutical Co., Transcenta Holding, Mabwell (Shanghai) Bioscience Co.. ## Investor discussion: VISEN Pharmaceuticals Members talk about VISEN Pharmaceuticals (2561). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at VISEN Pharmaceuticals, newest first. Each line links the filing it comes from. 1. 2026-04-27 Financings Share or debt issue: (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL OR TRANSFER TREASURY SHARES; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800071.pdf) 2. 2025-04-30 Financings Share or debt issue: (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL OR TRANSFER TREASURY SHARES; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0430/2025043001616.pdf) 3. 2025-03-12 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0313/2025031300017.pdf) ## Press releases Headlines of VISEN Pharmaceuticals's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-05 HKEXnews [RESIGNATION OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1005/2026100502093.pdf) 2. 2026-08-27 HKEXnews [(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026; (2) RESIGNATION OF DIRECTOR; AND (3) CHANGE OF COMPOSITION OF THE BOARD COMMITTEES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0827/2026082702121.pdf) 3. 2026-07-20 HKEXnews [GRANT OF SHARE AWARDS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0720/2026072001161.pdf) 4. 2026-06-26 HKEXnews [(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026; AND (2) APPOINTMENTS OF NON-EXECUTIVE DIRECTORS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062602201.pdf) 5. 2026-06-17 HKEXnews [SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0617/2026061701974.pdf) 6. 2026-06-17 HKEXnews [SUPPLEMENTAL CIRCULAR IN RELATION TO THE PROPOSED APPOINTMENT OF DIRECTORS BY REQUISITION AND SUPPLEMENTAL NOTICE OF THE ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0617/2026061701970.pdf) 7. 2026-04-27 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800077.pdf) 8. 2026-04-27 HKEXnews [(1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL OR TRANSFER TREASURY SHARES; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800071.pdf) 9. 2026-04-22 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0422/2026042201325.pdf) 10. 2026-03-26 HKEXnews [Continuing Connected Transactions](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 11. 2026-03-26 HKEXnews [NOTICE OF EGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032603150.pdf) 12. 2026-03-26 HKEXnews [(1) REVISION AND RENEWAL OF EXISTING ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE EXCLUSIVE LICENCE AGREEMENTS; (2) REVISION AND RENEWAL OF EXISTING ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 1st COMMERCIAL SUPPLY AGREEMENT; (3) REVISION OF EXISTING ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 2nd COMMERCIAL SUPPLY FRAMEWORK AGREEMENT; AND (4) NOTICE OF EGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032603096.pdf) 13. 2026-03-26 HKEXnews [(1) REVISION AND RENEWAL OF EXISTING ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE EXCLUSIVE LICENCE AGREEMENTS; (2) REVISION AND RENEWAL OF EXISTING ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 1st COMMERCIAL SUPPLY AGREEMENT; AND (3) REVISION OF EXISTING ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 2nd COMMERCIAL SUPPLY FRAMEWORK AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032603066.pdf) 14. 2026-03-12 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0312/2026031201396.pdf) 15. 2026-01-26 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT BIOLOGICS LICENSE APPLICATION FOR LONAPEGSOMATROPIN FOR INJECTION APPROVED BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0126/2026012601062.pdf) 16. 2025-10-13 HKEXnews [APPOINTMENT OF CHIEF FINANCIAL OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1013/2025101300852.pdf) 17. 2025-08-31 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE CONTINUING CONNECTED TRANSACTION - COMMERCIAL SUPPLY FRAMEWORK AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0831/2025083100495.pdf) 18. 2025-08-27 HKEXnews [(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MOTNHS ENDED JUNE 30, 2025; (2) RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082702203.pdf) 19. 2025-06-27 HKEXnews [(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 27 JUNE 2025; (2) RETIREMENT OF NON-EXECUTIVE DIRECTORS; (3) CHANGE OF CHAIRMAN OF THE BOARD; AND (4) CHANGE OF COMPOSITION OF NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0627/2025062703934.pdf) 20. 2025-06-12 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2561 on TradingView](https://www.tradingview.com/symbols/HKEX-2561/). ## Listing details VISEN Pharmaceuticals is a public biotech or pharmaceutical company listed on HKEX under the ticker 2561, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: VISEN Pharmaceuticals - **Ticker**: 2561 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG93Y5D1039 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2561/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/visen-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "VISEN Pharmaceuticals (2561) stock and investor profile", 2026-10-31, https://aibio.space/companies/visen-pharmaceuticals/